Table 2.
Untargeted analysis (relative significance in the groups’ separation) of HDL lipoproteins of the studied groups.
T2DM vs. Controls | CHD vs. T2DM | CHD vs. Controls | ||||
---|---|---|---|---|---|---|
Lipid Constituent | change | Coef | change | Coef | change | Coef |
Structural Components | ||||||
EC | ↓ | 13.52 | ↓ | 12.56 | ↓ | 33.57 |
FC | ↑ | 6.35 | ↓ | 15.88 | ↓ | 10.01 |
TG | ↑ | 2.11 | ↑ | 3.36 | ↑ | 6.81 |
PLs | ↓ | 3.03 | ↓ | 0.40 | ↓ | 1.91 |
PC | ↓ | 28.16 | ↓ | 8.52 | ↓ | 36.55 |
SM | ↓ | 20.40 | ↓ | 11.94 | ↓ | 47.09 |
LysoPC | ↑ | 11.66 | ↑ | 23.58 | ↑ | 37.41 |
PE | ↑ | 0.80 | ↓ | 0.40 | ↓ | 0.40 |
Plasmalogen | ↓ | 0.70 | ↑ | 0.10 | ↓ | 0.20 |
Qualitative Features of Fatty Acids | ||||||
SFA | ↑ | 26.40 | ↑ | 38.54 | ↑ | 41.04 |
UFA | ↓ | 17.41 | ↓ | 3.90 | ↓ | 15.54 |
PUFA | ↓ | 2.66 | ↓ | 1.43 | ↓ | 5.02 |
ω-3 FA | ↓ | 2.88 | ↓ | 2.49 | ↓ | 4.18 |
LA | ↑ | 2.38 | ↑ | 1.85 | ↓ | 4.40 |
EPA + AA | ↓ | 2.02 | ↓ | 0.16 | ↓ | 2.13 |
DHA | ↓ | 0.66 | ↑ | 1.50 | ↑ | 2.15 |